Products for Research Use Only

Cetraxate

CAT: 0804-HY-135759Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-135759Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cetraxate is an orally active antiulcer Drug. Cetraxate increases the blood flow of gastric mucosal. Cetraxate increases the eradication of Helicobacter pylori in smokers when in combination with Omeprazole , Amoxicillin (HY-B0467A), and Clarithromycin (HY-17508).
CAS Number
34675-84-8
UNSPSC
12352005
Hazard Statement
H301-H311-H331
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cetraxate.html
Solubility
10 mM in DMSO
Smiles
OC(CCC(C=C1)=CC=C1OC([C@H]2CC[C@@H](CC2)CN)=O)=O
Molecular Formula
C17H23NO4
Molecular Weight
305.37
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361+P364-P405-P501
References & Citations
[1]Kamada T, et al. Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. Aliment Pharmacol Ther. 2000 Aug;14 (8) :1089-94.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched